Patient Advocacy

Innovative Collaborations to Speed Science to Patients

11:00 AM–12:00 PM Jun 5, 2019 (US - Eastern)

112AB, Level 100


The session will address:
• Why deprioritized compounds still offer the potential to help address unmet medical needs for certain patient communities and are worth advancing.
• Barriers to developing medicines for specific patient populations and how to get innovation to where it’s needed.
• Different mechanisms for bringing products to market by affiliating with organizations that can improve access.
• What’s changing with the traditional model and why now is the right time for change.

Session ID: 560554